Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by Cavailles
Group name EquipeVC
Item Type Journal Article
Title The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status
Creator Jeschke et al.
Author Udo Jeschke
Author Xi Zhang
Author Christina Kuhn
Author Stéphan Jalaguier
Author Jacques Colinge
Author Kristina Pfender
Author Doris Mayr
Author Nina Ditsch
Author Nadia Harbeck
Author Sven Mahner
Author Sophie Sixou
Author Vincent Cavaillès
Abstract Increasing evidence implicates the aryl hydrocarbon receptor (AhR) as a possible regulator of mammary carcinogenesis. This study aims to clarify its prognostic impact in breast cancer (BC). Meta-analyses performed at the mRNA level demonstrated that the predictive value of AhR expression in BC depends on the lymph node (LN) status. AhR expression and sub-cellular location were then analyzed by immunohistochemistry in 302 primary BC samples. AhR was expressed in almost 90% of cases with a predominant nuclear location. Nuclear and cytoplasmic AhR levels were significantly correlated and associated with the expression of RIP140 (receptor-interacting protein of 140 kDa), an AhR transcriptional coregulator and target gene. Interestingly, total and nuclear AhR levels were only significantly correlated with short overall survival in node-negative patients. In this sub-group, total and nuclear AhR expression had an even stronger prognostic impact in patients with low RIP140-expressing tumors. Very interestingly, the total AhR prognostic value was also significant in luminal-like BCs and was an independent prognostic marker for LN-negative patients. Altogether, this study suggests that AhR is a marker of poor prognosis for patients with LN-negative luminal-like BCs, which warrants further evaluation.
Publication International Journal of Molecular Sciences
Volume 20
Issue 5
Date Feb 26, 2019
Journal Abbr Int J Mol Sci
Language eng
DOI 10.3390/ijms20051016
ISSN 1422-0067
Library Catalog PubMed
Extra PMID: 30813617 PMCID: PMC6429124
Tags AhR, breast cancer, Breast Neoplasms, Female, Gene Expression Regulation, Neoplastic, Humans, last, luminal-like, lymph node, Lymph Nodes, Nuclear Receptor Interacting Protein 1, original, own, Prognosis, prognostic marker, Receptors, Aryl Hydrocarbon, RIP140, RNA, Messenger, Survival Analysis
Date Added 2019/05/16 - 11:11:31
Date Modified 2023/11/21 - 14:22:30
Notes and Attachments PubMed entry (Attachment)
PubMed entry (Attachment)
Texte intégral (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés